Genetic Architectures of Myeloid Dysregulation in Severe COVID-19
Viruses · 26.05.2026 · 18 (6) · 604
DOI: 10.3390/v18060604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 26.05.2026. Verfasst von Darya A Kashatnikova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: COVID-19, Myelopoiesis, Myeloid Cells. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of Russia.
Abstract (Originalsprache)
Background
Dysregulated myeloid responses are central to severe COVID-19, but the contribution of host genetics to this “emergency myelopoiesis” is poorly understood.
Methods
We performed whole-exome sequencing in 77 hospitalized COVID-19 patients to analyze the impact of the cumulative burden of rare, high-impact variants (qualifying variants, QVs) in hemopoietic and inflammatory gene sets on longitudinal leukocyte counts. Predictive models were validated using repeated internal cross-validation (1000 resamples) and external population-scale exome data (Genebass, n > 380,000).
Results
The QV burden was a significant predictor of peak neutrophil and monocyte counts, independent of age, sex, and clinical severity. This association remained robust in a microbiologically confirmed “pure viral” subcohort (n = 54) and was stable across internal cross-validation resamples. External validation revealed an 11.2-fold enrichment of myeloid-associated genes within our candidate gene sets (p ≈ 2.2 × 10−63). Patients with a high QV burden exhibited significantly worse outcomes, including a four-fold increase in mortality (p = 0.00065), and a genetic profile linked to hyper-inflammation and thrombosis.
Conclusion
These findings suggest that host genetic architecture may contribute to the magnitude of myeloid dysregulation in acute viral infection. Genetic stratification could identify patients predisposed to a hyperactive myeloid response, potentially guiding early, targeted immunomodulation to mitigate severe complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
- Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 107031 Moscow, Russia.
ORCID-Profile: Darya A Kashatnikova, Alesya S Gracheva, Artem N Kuzovlev, Lyubov E Salnikova
Förderung
- Ministry of Education and Science of Russia
Zitieren
APA
Kashatnikova, D. A., Gracheva, A. S., Kuzovlev, A. N., & Salnikova, L. E. (2026). Genetic Architectures of Myeloid Dysregulation in Severe COVID-19. Viruses, 18(6), 604. https://doi.org/10.3390/v18060604
Vancouver
Kashatnikova DA, Gracheva AS, Kuzovlev AN, Salnikova LE. Genetic Architectures of Myeloid Dysregulation in Severe COVID-19. Viruses. 2026;18(6):604. doi:10.3390/v18060604
BibTeX
@article{Kashatnikova2026,
author = {Kashatnikova, Darya A and Gracheva, Alesya S and Kuzovlev, Artem N and Salnikova, Lyubov E},
title = {Genetic Architectures of Myeloid Dysregulation in Severe COVID-19},
journal = {Viruses},
year = {2026},
volume = {18},
number = {6},
pages = {604},
doi = {10.3390/v18060604}
}
EUVIMED